$889.9 M

GRCL Mkt cap, 15-Oct-2021
Gracell Net income (FY, 2019)-138.7 M
Gracell EBIT (FY, 2019)-146.6 M
Gracell Cash, 30-Sept-2020156.8 M
Gracell EV798 M
Get notified regarding key financial metrics and revenue changes at GracellLearn more
Banner background

Gracell Income Statement

Annual

CNYFY, 2018FY, 2019

R&D expense

52.2m119.2m

General and administrative expense

10.3m27.4m

Operating expense total

62.5m146.6m

EBIT

(62.5m)(146.6m)

Interest income

1.4m3.9m

Pre tax profit

(60.8m)(138.7m)

Net Income

(60.8m)(138.7m)

EPS

(0.7)(2.0)

Gracell Balance Sheet

Annual

CNYFY, 2018FY, 2019

Cash

11.9m312.1m

Prepaid Expenses

4.5m5.4m

Current Assets

128.0m340.4m

PP&E

16.3m48.3m

Total Assets

148.5m412.2m

Current Liabilities

7.4m18.2m

Total Liabilities

146.1m156.9m

Common Stock

69.0k68.0k

Preferred Stock

83.4m547.8m

Retained Earnings

(81.1m)(289.4m)

Total Equity

(81.0m)(292.5m)

Financial Leverage

-1.8 x-1.4 x

Quarterly

CNYQ3, 2020

Cash

156.8m

Prepaid Expenses

3.8m

Current Assets

215.7m

PP&E

112.1m

Total Assets

340.6m

Short-term debt

20.2m

Current Liabilities

32.2m

Long-term debt

44.6m

Total Debt

64.9m

Total Liabilities

76.8m

Common Stock

68.0k

Preferred Stock

732.9m

Retained Earnings

(464.1m)

Total Equity

(469.1m)

Debt to Equity Ratio

-0.1 x

Debt to Assets Ratio

0.2 x

Financial Leverage

-0.7 x

Gracell Cash Flow

Annual

CNYFY, 2018FY, 2019

Net Income

(60.8m)(138.7m)

Depreciation and Amortization

3.0m5.1m

Cash From Operating Activities

(61.9m)(135.4m)

Purchases of PP&E

(11.4m)(56.4m)

Cash From Investing Activities

(113.4m)41.4m

Long-term Borrowings

(10.0m)

Cash From Financing Activities

138.7m394.8m

Net Change in Cash

(36.5m)300.2m

Quarterly

USDQ3, 2019Q3, 2020

Net Income

(95.9m)(128.3m)

Depreciation and Amortization

3.8m12.2m

Cash From Operating Activities

(102.6m)(134.2m)

Purchases of PP&E

(46.2m)(65.3m)

Cash From Investing Activities

42.7m(81.8m)

Cash From Financing Activities

394.8m63.3m

Net Change in Cash

338.1m(155.3m)

Gracell Ratios

CNYFY, 2018

Financial Leverage

-1.8 x

Gracell Operating Metrics

Q3, 2020

Preclinical Phase Products

1

Phase I Trials Products

4